Initiates Coverage on Calithera Biosciences (NASDAQ:CALA) initiated coverage on shares of Calithera Biosciences (NASDAQ:CALAFree Report) in a research note issued to investors on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

NASDAQ:CALA opened at $0.02 on Thursday. Calithera Biosciences has a 1 year low of $0.02 and a 1 year high of $0.50. The stock has a 50-day simple moving average of $0.02 and a 200-day simple moving average of $0.03.

About Calithera Biosciences

(Get Free Report)

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.

See Also

Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with's FREE daily email newsletter.